BS Identity and Score for SOLIRIS (Alexion Pharmaceuticals)

AI only sees the HTML that arrives on first response — everything else is invisible. Expose your real text only footprint and find out which parts of your site never reach an AI crawler at all.

Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.

The site avoids standard trust theatre like unverified customer reviews (review_count 0). However, it makes significant claims about being studied in over 50 clinical trials without providing a direct proof path or external links to those studies (proof_links_count 0). The reliance on internal brochures rather than external peer-reviewed citations in the crawl data constitutes a proof gap.

The ratio of substance to fluff is high, but the ratio of verifiable evidence (external links) to assertions is low. The site relies on the user trusting the FDA-approved status as the ultimate proof, which allows it to omit granular data summaries. For every 5 technical assertions about indications, there is 0 direct outbound links to independent clinical validation in the provided data.

To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.

There is a significant technical authority gap as the site lacks any structured data (schema_json is null). For a multi-billion dollar pharmaceutical brand, the absence of Organization or Product schema is a major technical oversight. Furthermore, reference to Alexion Nurse Case Managers provides no verifiable digital footprint or professional credentials for the individuals involved.

The marketing tone of Tried. Tested. Proven. is backed by the mention of 50 trials, but the site fails to display actual data points from those trials in the text. There is a disconnect between the claim of 15 years of experience and the lack of specific real-world evidence metrics beyond general safety warnings. Most clinical claims are buried in downloadable brochures rather than being transparently proved on the page.

The content perfectly aligns with the Pharma and Biotech industry, characterized by high-density regulatory disclosures, Boxed Warnings, and specific clinical indications. The presence of detailed safety protocols and REMS program information confirms this is a legitimate medical product site.

A page that loads perfectly for users can still return an empty shell to an AI crawler. Examine the Crawlability Technical Guide and understand why script free extraction is the real measure of visibility.

“The score of 33 is driven largely by technical identity gaps (Step 5) and the lack of external proof paths (Step 3). While the medical content is dense and substantively accurate, the site's strategic shift toward a different product on its sub-pages creates a unique form of semantic drift that slightly inflates the BS score.”